Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Kreiner, Frederik F ^a   Galbo, Henrik ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CORTICOTROPIN; ETANERCEPT; FOLLITROPIN; HYDROCORTISONE; INTERLEUKIN 6; PREDNISOLONE; PROLACTIN; SOMATOMEDIN C; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADRENALIN BLOOD LEVEL; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; NEUROENDOCRINE SYSTEM; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA; SINGLE BLIND PROCEDURE; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; ANTAGONISTS AND INHIBITORS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METABOLISM; NEUROSECRETION; POLYMYALGIA RHEUMATICA;

AGED; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOGLOBULIN G; MALE; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; POLYMYALGIA RHEUMATICA; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864950857     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4017     Document Type: Article

References (36)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002, 347:261-271. 10.1056/NEJMra011913, 12140303.
2. Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C. Adrenal gland hypofunction in active polymyalgia rheumatica: effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 2002, 29:748-756.
3. Kreiner F, Langberg H, Galbo H. Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis Rheum 2010, 62:3768-3775. 10.1002/art.27728, 20812339.
4. Kreiner F, Galbo H. Elevated muscle interstitial levels of pain-inducing substances in symptomatic muscles in patients with polymyalgia rheumatica. Pain 2011, 152:1127-1132. 10.1016/j.pain.2011.01.032, 21388741.
5. Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C. Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology 2009, 48:1566-1569. 10.1093/rheumatology/kep286, 19808693.
6. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, Focherini MC, Frizziero L, Facchini A. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatic: quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996, 39:1199-1207. 10.1002/art.1780390719, 8670331.
7. Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008, 44:207-220. 10.1016/j.cyto.2008.09.004, 18986814.
8. Kreiner F, Galbo H. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scand J Rheumatol 2010, 39:402-408. 10.3109/03009741003631479, 20615159.
9. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993, 36:1286-1294. 10.1002/art.1780360913, 8216422.
10. Dasgupta B, Panayi GS. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1990, 29:456-458. 10.1093/rheumatology/29.6.456, 2124160.
11. Cutolo M, Montecucco CM, Cavagna L, Caporali R, Capellino S, Montagna P, Fazzuoli L, Villaggio B, Seriolo B, Sulli A. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006, 65:1438-1443. 10.1136/ard.2006.051979, 1798362, 16644782.
12. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77:1690-1694. 10.1210/jc.77.6.1690, 8263159.
13. Kreiner F, Galbo H. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthritis Res Ther 2010, 12:R176. 10.1186/ar3140, 2991007, 20854662.
14. Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein SR, Stromeyer P, Drechsler S, Fehm HL, Porzsolt F. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab 1994, 79:1212-1214. 10.1210/jc.79.4.1212, 7962296.
15. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997, 66:54-62. 10.1159/000127219, 9258919.
16. Straub RH, Harle P, Sarzi-Puttini P, Cutolo M. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis Rheum 2006, 54:2039-2046. 10.1002/art.21946, 16802339.
17. Demir H, Tanriverdi F, Ozoǧul N, Caliş M, Kirnap M, Durak AC, Keleştimur F. Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls. Scand J Rheumatol 2006, 35:217-223. 10.1080/03009740500474586, 16766369.
18. Straub RH, Georgi J, Helmke K, Vaith P, Lang B. In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers. Rheumatology 2002, 41:423-429. 10.1093/rheumatology/41.4.423, 11961173.
19. Pacheco MJB, Amado JA, Lopez-Hoyos M, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, Martinez-Taboada VM. Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003, 32:266-272. 10.1053/sarh.2003.49993, 12621591.
20. Straub RH, Glück T, Cutolo M, Georgi J, Helmke K, Scholmerich J, Vaith P, Lang B. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology 2000, 39:624-631. 10.1093/rheumatology/39.6.624, 10888707.
21. Straub RH, Cutolo M. Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica. J Rheumatol 2006, 33:1219-1223.
22. Sathi N, Makkuni D, Mitchell WS, Swinson D, Chattopadhyay C. Musculoskeletal aspects of hypoadrenalism: just a load of aches and pains?. Clin Rheumatol 2009, 28:631-638. 10.1007/s10067-009-1126-y, 19266139.
23. Narváez J, Bernad B, Díaz Torné C, Momplet JV, Montpel JZ, Nolla JM, Valverde-García J. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis. J Rheumatol 2006, 33:1293-1298.
24. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680.
25. Straub RH, Buttgereit F, Cutolo M. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases: a role for misguided energy regulation. Clin Rheumatol 2011, 29:S23-S31.
26. Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002, 46:654-662. 10.1002/art.10177, 11920401.
27. Selye H. Stress Without Distress. 1974, New York: Lippincott Williams & Wilkins;, 1.
28. Vanhorebeek I, Langouche L, Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2:20-31.
29. Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz H-M. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003, 48:1504-1512. 10.1002/art.11036, 12794817.
30. Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz H-M, Tak PP, Sarzi-Puttini P. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum 2008, 58:976-984. 10.1002/art.23385, 18383357.
31. Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Rheumatol 2004, 22:63-70.
32. Härle P, Straub RH, Wiest R, Mayer A, Scholmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis 2006, 65:51-56. 10.1136/ard.2005.038059, 1797997, 15941834.
33. Di Comite G, Marinosci A, Di Matteo P, Manfredi A, Rovere-Querini P, Baldissera E, Aiello P, Corti A, Sabbadini MG. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann N Y Acad Sci 2006, 1069:428-437. 10.1196/annals.1351.041, 16855170.
34. Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol 2009, 40:50-59.
35. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990, 71:1567-1572. 10.1210/jcem-71-6-1567, 2229314.
36. Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BAC, Bos WH, Simsek S, Lips P, van de Stadt RJ, de Koning MHMT, Nurmohamed MT. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol 2011, 38:247-251. 10.3899/jrheum.100488, 21078720.